Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angelina Kuzmenko
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0009-0001-1746-2549
Observed ORCID:
0009-0001-1746-2549
OpenAlex ID:
A5111247445
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
2026
·
Georgina V. Long
, Inês Pires da Silva
, et al.
·
Nature Medicine
·
1
PDF
Neoadjuvant anti–PD-1 prolgolimab monotherapy in resectable high-risk melanoma: Pathologic response and early event-free survival in a prospective single-arm phase II CRISTINA study.
2026
·
Angelina Kuzmenko
, Igor V. Samoylenko
, et al.
·
Journal of Clinical Oncology
Prognostic insights in skin melanoma: A study of differential diagnostic tissue markers.
2025
·
Igor Samoylenko
, Andrew R. Zaretsky
, et al.
·
Journal of Clinical Oncology
Mucosal melanoma treatment patterns and outcomes in real clinical practice: Single institution experience.
2024
·
Igor Samoylenko
, Anna Stroganova
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type